In patients with pseudo-severe AS, the 5-year survival under conservative treatment is better than in true-severe AS and comparable with that of propensity-matched patients with LV systolic dysfunction and no evidence of valve disease. Further studies are needed to define optimal therapeutic management in these patients.
Fougères, E., Tribouilloy, C., Monchi, M., Petit-Eisenmann, H., Baleynaud, S., Chauvel, C., Pasquet, A., Metz, D., Adams, C., Rusinaru, D., Guéret, P., & Monin, J.-L. (2012). Outcomes of pseudo-severe aortic stenosis under conservative treatment. European Heart Journal (English Edition), 33(19), 2426-2433. https://doi.org/10.1093/eurheartj/ehs176 (Original work published 2012)